0001817875-20-000001.txt : 20200715 0001817875-20-000001.hdr.sgml : 20200715 20200714181037 ACCESSION NUMBER: 0001817875-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200715 DATE AS OF CHANGE: 20200714 EFFECTIVENESS DATE: 20200715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gaiamer Biotechnologies, Inc. CENTRAL INDEX KEY: 0001817875 IRS NUMBER: 845169488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-371022 FILM NUMBER: 201027972 BUSINESS ADDRESS: STREET 1: 5768 LINDENHURST AVE. CITY: LOS ANGELES STATE: CA ZIP: 90036 BUSINESS PHONE: 3239650063 MAIL ADDRESS: STREET 1: 5768 LINDENHURST AVE. CITY: LOS ANGELES STATE: CA ZIP: 90036 D 1 primary_doc.xml X0708 D LIVE 0001817875 Gaiamer Biotechnologies, Inc. 5768 LINDENHURST AVE. LOS ANGELES CA CALIFORNIA 90036 3239650063 DELAWARE None None Corporation true 2020 Charles Caliman 1100 Wilshire Blvd. #2809 Los Angeles CA CALIFORNIA 90017 Executive Officer Director Jihene Dhaouadi 2105 East Broadway Unit 308 Long Beach CA CALIFORNIA 90803 Director Araya Mesfin 600 Northpark Town Center 1200 Abernathy Suite 1850 Atlanta GA GEORGIA 30328 Director Christopher Sargent 11206 Beecher Road Flushing MI MICHIGAN 48433 Executive Officer Director Jerry Schindler 4326 Oglethorpe Loop N.W. Acworth GA GEORGIA 30101 Director Keith Tinsley 13536 Lakewood Blvd. Bellflower CA CALIFORNIA 90706 Executive Officer Director Thomas Trimbach 5768 Lindenhurst Ave. Los Angeles CA CALIFORNIA 90036 Executive Officer Director Manufacturing No Revenues 06b false 2020-06-24 false true true false 25000 Blue Horse Equity LLC None None None 260 Newport Center Drive Suite 100 Newport Beach CA CALIFORNIA 92660 AZ ARIZONA CA CALIFORNIA FL FLORIDA GA GEORGIA IL ILLINOIS MI MICHIGAN NV NEVADA NY NEW YORK TX TEXAS true 5000000 100000 4900000 false 1 600000 true 0 Stock-based commissions, the value of which is difficult to ascertain currently, will be paid to certain executive officers of the company in connection with the offering. 480000 true false Gaiamer Biotechnologies, Inc. Charles Caliman Charles Caliman Director & General Counsel 2020-07-14